Skip to main content
. 2019 Jul 15;18(3):2931–2938. doi: 10.3892/ol.2019.10619

Figure 4.

Figure 4.

Knockout of ZEB2 suppresses the development of NSCLC. (A) The expression levels of ZEB2 in NSCLC tissues. (B) ZEB2 expression in H522, A549, H650 and HBECs cell lines. (C) The expression of ZEB2 was examined in A549 cells with ZEB2 siRNA. (D) Cell proliferation was measured in cells containing ZEB2 siRNA. (E and F) Migration and invasion analysis in cells containing ZEB2 siRNA. *P<0.05, **P<0.01. ZEB2, zinc finger E-box-binding homeobox 2; NSCLC, non-small cell lung cancer; NC, negative control.